OXYGENTAPH · OXYGENTA PHARMACEUTICAL LIMITE · Financials
Market Cap
1.88B INR
Shares
36.98M
Volume · Nov 13
6751
Avg daily vol (3M)
13.33K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.13B
+3.4%
FY2026
Net Income
-175.72M
-70.6%
FY2026
Operating Cash Flow
-277.53M
-1166.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 1.54B | 1.13B | 1.09B |
| INR | 19.5M | 23.23M | 17.82M |
| INR | 83.88M | 47.77M | 36.14M |
| INR | -135.09M | -221.8M | -143.51M |
| INR | -21.23M | -46.09M | -40.53M |
| INR | -113.86M | -175.72M | -102.98M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.